Regencell Extends Director/Employee Stock Lock-up to April 2026
Ticker: RGC · Form: 6-K · Filed: 2025-01-15T00:00:00.000Z
Sentiment: neutral
Topics: lock-up, insider-holding, directors-employees
TL;DR
Regencell directors/employees locked up shares until April 2026, signaling confidence.
AI Summary
Regencell Bioscience Holdings Limited announced on January 15, 2025, that all directors and employees who received stock options have agreed to an extended lock-up period. This new undertaking will keep their shares locked up for an additional 15 months, extending the lock-up until April 20, 2026.
Why It Matters
This extension of the lock-up period for directors and employees suggests a commitment to long-term stability and may reduce immediate selling pressure on the stock.
Risk Assessment
Risk Level: low — This filing is a routine announcement regarding a lock-up agreement and does not contain significant financial or operational changes.
Key Players & Entities
- Regencell Bioscience Holdings Limited (company) — The company making the announcement.
- April 20, 2026 (date) — The new expiration date for the lock-up undertaking.
- 15 months (duration) — The additional period for the lock-up.
FAQ
What is the new expiration date for the lock-up undertaking?
The lock-up undertaking will now extend until April 20, 2026.
Who is subject to this extended lock-up agreement?
All directors and employees who were previously granted stock options are subject to the extended lock-up.
What is the duration of the additional lock-up period?
The additional lock-up period is for 15 months.
What form is attached as an exhibit to this filing?
A form of the lock-up undertaking is attached as Exhibit 99.1.
What is the Commission File Number for Regencell Bioscience Holdings Limited?
The Commission File Number is 001-40617.
Filing Stats: 241 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2025-01-15 06:02:56
Filing Documents
- ea0227584-6k_regencell.htm (6-K) — 11KB
- ea022758401ex99-1_regencell.htm (EX-99.1) — 10KB
- 0001213900-25-003587.txt ( ) — 22KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: January 15, 2025 Regencell Bioscience Holdings Limited By: /s/ Yat-Gai Au Name: Yat-Gai Au Title: Chief Executive Officer and Chairman of the Board of Directors [Signature Page to Form 6-K] 2 EXHIBIT INDEX Exhibit No. Description 99.1 Form of Letter of Lock-up Undertaking 3